Targeted Contrast Agents for Molecular MRI

Abstract : Molecular magnetic resonance imaging (MRI) provides information non-invasively at cellular and molecular levels, for both early diagnosis and monitoring therapeutic follow-up. This imaging technique requires the development of a new class of contrast agents, which signal changes (typically becomes enhanced) when in presence of the cellular or molecular process to be evaluated. Even if molecular MRI has had a prominent role in the advances in medicine over the past two decades, the large majority of the developed probes to date are still in preclinical level, or eventually in phase I or II clinical trials. The development of novel imaging probes is an emergent active research domain. This review focuses on gadolinium-based specific-targeted contrast agents, providing rational design considerations and examples of the strategies recently reported in the literature.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02068580
Contributor : Laëtitia Legoupil <>
Submitted on : Friday, March 15, 2019 - 9:49:27 AM
Last modification on : Thursday, April 11, 2019 - 11:34:05 AM

Links full text

Identifiers

Collections

Citation

Sara Lacerda. Targeted Contrast Agents for Molecular MRI. Inorganics, MDPI AG, 2018, 6 (4), pp.129. ⟨10.3390/inorganics6040129⟩. ⟨hal-02068580⟩

Share

Metrics

Record views

11